
Laura Alder, MD, is a medical oncologist with subspecialty expertise in thoracic oncology. She is an Assistant Professor of Medicine at the Duke University School of Medicine and a member of the Duke Cancer Institute, where she cares for patients at the Duke Cancer Center in close collaboration with a multidisciplinary thoracic team. She has leadership within the Duke Center for Brain and Spine Metastasis and the Phase One clinical trial program. Clinically, Dr. Alder focuses on thoracic oncology, precision treatment strategies, and complex multidisciplinary cancer care. Her research centers on biomarker-driven precision oncology, discovery of novel therapeutic targets across disease stages, and advancing health equity and access in cancer care. She leads multiple clinical trials and translational research efforts in SCLC (small cell lung cancer). She serves on the IASLC Rare Tumors Committee and the Alliance Respiratory Committee. Her work has been recognized with a fellowship grant from the Lung Cancer Initiative of North Carolina. Dr. Alder earned her medical degree from the Ochsner Health program, completed an Internal Medicine residency at Virginia Commonwealth University, and a Hematology-Oncology fellowship at Duke University Medical Center.
Assistant Professor
Residency
2017 – 2020
Fellowship
2020 – 2023